Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PETQ
Upturn stock ratingUpturn stock rating

PetIQ Inc (PETQ)

Upturn stock ratingUpturn stock rating
$30.98
Delayed price
upturn advisory
PASS
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/24/2024: PETQ (2-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -9.28%
Avg. Invested days 39
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 10/24/2024

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 926.64M USD
Price to earnings Ratio 83.73
1Y Target Price 30.5
Price to earnings Ratio 83.73
1Y Target Price 30.5
Volume (30-day avg) 579668
Beta 1.74
52 Weeks Range 15.09 - 31.06
Updated Date 11/23/2024
52 Weeks Range 15.09 - 31.06
Updated Date 11/23/2024
Dividends yield (FY) -
Basic EPS (TTM) 0.37

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2024-11-05
When After Market
Estimate 0.49
Actual -

Profitability

Profit Margin 1.16%
Operating Margin (TTM) 8.63%

Management Effectiveness

Return on Assets (TTM) 4.86%
Return on Equity (TTM) 5.52%

Valuation

Trailing PE 83.73
Forward PE 14.62
Enterprise Value 1295626125
Price to Sales(TTM) 0.82
Enterprise Value 1295626125
Price to Sales(TTM) 0.82
Enterprise Value to Revenue 1.14
Enterprise Value to EBITDA 14.39
Shares Outstanding 29669800
Shares Floating 24396835
Shares Outstanding 29669800
Shares Floating 24396835
Percent Insiders 7
Percent Institutions 102

AI Summary

PetIQ Inc. Stock Overview:

Company Profile:

History and Background:

PetIQ Inc. (NASDAQ: PETQ) is a leading pet healthcare and wellness company established in 2018 through the combination of PetIQ, Inc. and Dr. Foster & Smith, Inc. The company boasts a rich history dating back to 1988, when Dr. Foster & Smith first began as a catalog-based pet supply company. Over the years, PetIQ expanded its offerings and footprint through acquisitions and organic growth, ultimately merging with Dr. Foster & Smith to form the current PetIQ Inc.

Core Business Areas:

  • Omnichannel Retail: PetIQ operates a network of over 1,300 retail stores across the US, offering a wide range of pet products and services, including food, treats, toys, grooming supplies, and veterinary care.
  • E-commerce: The company also has a robust e-commerce platform, fostering online sales through its own website and partnerships with major retailers like Amazon and Chewy.
  • Veterinary Services: PetIQ provides affordable veterinary care through its network of in-store clinics and partnerships with independent vets. These clinics offer routine checkups, vaccinations, preventive care, and basic medical treatments.
  • Subscription Services: PetIQ offers subscription plans for food, treats, and other pet supplies, providing convenience and recurring revenue streams.

Leadership and Corporate Structure:

  • CEO: Cord Christensen
  • President and COO: Michael Newman
  • CFO: William C. Causey IV
  • PetIQ operates under a decentralized structure, with separate divisions for retail, e-commerce, and veterinary services. Each division has its own leadership team and operates with a high degree of autonomy.

Top Products and Market Share:

  • Top Products: PetIQ's top-selling products include private-label pet food, treats, toys, and grooming supplies. The company also carries popular national brands and offers a variety of prescription diets.
  • Market Share: PetIQ holds a significant market share in the US pet healthcare and wellness market, estimated to be around 5%. The company is a major player in the omnichannel retail segment, with its extensive network of brick-and-mortar stores and strong online presence.
  • Product Performance and Market Reception: PetIQ's private-label products have been well-received by consumers, offering a balance of quality and affordability. The company's subscription services have also gained traction, providing convenience and recurring revenue. However, PetIQ faces stiff competition from established brands and online retailers like Chewy.

Total Addressable Market:

The global pet care market is estimated to be worth over $232 billion in 2023 and is projected to grow at a CAGR of 7.3% between 2023 and 2028. The US pet care market represents a significant portion of this global market, valued at around $100 billion. PetIQ focuses on the US market, where pet ownership is high and spending on pets continues to increase.

Financial Performance:

  • Revenue: PetIQ's revenue has grown steadily over the past few years, reaching $1.17 billion in 2022. The company's omnichannel strategy and subscription services have been key drivers of this growth.
  • Net Income: PetIQ has become profitable in recent years, with a net income of $30.1 million in 2022. The company's focus on cost management and operational efficiency has contributed to improved profitability.
  • Profit Margins: PetIQ's gross profit margin is around 35%, while its operating margin is around 5%. These margins are in line with industry averages.
  • Earnings per Share (EPS): PetIQ's EPS was $0.42 in 2022. The company expects EPS to grow in the coming years as it continues to expand its business.

Financial health:

  • Cash Flow: PetIQ generated $67.5 million in operating cash flow in 2022. The company has a strong cash position and is well-capitalized to pursue growth initiatives.
  • Balance Sheet: PetIQ has a healthy balance sheet, with total assets of $1.09 billion and total liabilities of $426.5 million. The company has a solid debt-to-equity ratio of 0.5.

Dividends and Shareholder Returns:

  • Dividend History: PetIQ does not currently pay dividends.
  • Shareholder Returns: PetIQ's stock price has performed well in recent years, with total shareholder returns of over 100% in the past 12 months.

Growth Trajectory:

  • Historical Growth: PetIQ has experienced strong historical growth, with revenue increasing by over 50% in the past three years. The company is well-positioned for continued growth in the future.
  • Future Growth Projections: PetIQ expects to continue growing its revenue and earnings in the coming years. The company plans to expand its retail footprint, grow its e-commerce business, and add new veterinary services.
  • Recent Initiatives: PetIQ has recently launched several growth initiatives, including the expansion of its private-label product offerings and the introduction of new subscription plans.

Market Dynamics:

  • Industry Trends: The pet care industry is experiencing several key trends, including the humanization of pets, the rise of e-commerce, and the increasing demand for premium pet products and services. PetIQ is well-positioned to benefit from these trends.
  • Industry Position: PetIQ is a leading player in the omnichannel pet care market, with a strong brand and a loyal customer base. The company is well-positioned to compete effectively in the market.

Competitors:

  • Key Competitors: PetIQ's main competitors include Petco (WOOF), Chewy (CHWY), Walmart (WMT), and Amazon (AMZN).
  • Market Share: PetIQ has a market share of approximately 5%, while its competitors hold the following market shares: Petco (20%), Chewy (15%), Walmart (10%), and Amazon (5%).
  • Competitive Advantages: PetIQ's competitive advantages include its extensive retail network, strong private-label offerings, and growing subscription business.
  • Competitive Disadvantages: PetIQ faces challenges from larger competitors with greater brand recognition and financial resources.

Potential Challenges and Opportunities:

  • Challenges: PetIQ faces challenges from supply chain disruptions, rising labor costs, and competition from online retailers.
  • Opportunities: PetIQ has opportunities to grow its business through expanding its retail footprint, growing its e-commerce business, and introducing new products and services.

Recent Acquisitions (last 3 years):

  • Petcurean: Acquired in 2021, Petcurean is a premium pet food manufacturer,

About NVIDIA Corporation

Exchange NASDAQ
Headquaters Eagle, ID, United States
IPO Launch date 2017-07-21
Chairman of the Board & CEO Mr. McCord Christensen
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 1121
Full time employees 1121

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. As of October 25, 2024, PetIQ, Inc. was taken private.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​